Taysha Gene Therapies (TSHA) PT Raised to $11 at Citizens on REVEAL Data Update

June 23, 2026 4:40 AM

Citizens analyst Silvan Tuerkcan raised the price target on Taysha Gene Therapies (NASDAQ: TSHA) to $11.00 (from $8.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found